FTC Solar Upgraded to Buy by UBS as New Trackers Gain Orders
UBS says a depressed valuation misses earnings power from revamped 1P and First Solar trackers.
Already have an account? Sign in.
UBS says a depressed valuation misses earnings power from revamped 1P and First Solar trackers.
Leerink cut Bristol Myers and raised Zentalis. Barclays lowered uniQure. Cantor upgraded Rezolute. New Buy calls on Ovid, Maravai, and Regenxbio.
Morgan Stanley keeps a bullish view on SpaceX, citing growth and a cheaper way into the space and intelligence economy ahead of Flight 15.
Option Care Health is in advanced talks on a joint bid from McKesson and CD&R valuing it at more than $5 billion, including debt.